Literature DB >> 16982923

Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor.

Myew-Ling Toh1, Daniel Aeberli, Derek Lacey, Yuan Yang, Leilani L Santos, Michael Clarkson, Laveena Sharma, Colin Clyne, Eric F Morand.   

Abstract

Macrophage migration inhibitory factor (MIF) has a key role in regulation of innate and adaptive immunity and is implicated in sepsis, tumorigenesis, and autoimmune disease. MIF deficiency or immunoneutralization leads to protection against fatal endotoxic, exotoxic, and infective shock, and anti-inflammatory effects in other experimental models of inflammatory disease. We report a novel regulatory role of MIF in type 1 IL-1R and p55 TNFR expression and function. Compared with wild-type cells, MIF-deficient cells were hyporesponsive to IL-1- and TNF-induced MAPK activity, AP-1 activity, and cellular proliferation, while NF-kappaB function was preserved. Hyporesponsiveness of MIF-deficient cells was associated with down-regulation of cytokine receptor expression, which was restored by reconstitution of either an upstream kinase of MAPK, MAPK/ERK kinase, or MIF. These data suggest that endogenous MIF is required for cytokine activation of MAPK/AP-1 and cytokine receptor expression. This autocrine regulatory pathway defines an important amplifying role of endogenous MIF in cytokine-mediated immune and inflammatory diseases and provides further molecular evidence for the critical role of MIF in cellular activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982923     DOI: 10.4049/jimmunol.177.7.4818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

2.  Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper.

Authors:  Huapeng Fan; Wenping Kao; Yuan H Yang; Ran Gu; James Harris; Günter Fingerle-Rowson; Richard Bucala; Devi Ngo; Elaine Beaulieu; Eric F Morand
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

3.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

4.  Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Authors:  Huapeng Fan; Pam Hall; Leilani L Santos; Julia L Gregory; Gunter Fingerle-Rowson; Richard Bucala; Eric F Morand; Michael J Hickey
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

5.  Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Authors:  Cédric Carli; Christine N Metz; Yousef Al-Abed; Paul H Naccache; Ali Akoum
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

6.  Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Authors:  Eduardo G Regis; Victor Barreto-de-Souza; Mariza G Morgado; Marcelo T Bozza; Lin Leng; Richard Bucala; Dumith C Bou-Habib
Journal:  Virology       Date:  2010-01-20       Impact factor: 3.616

7.  Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.

Authors:  L L Santos; A Dacumos; J Yamana; L Sharma; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

8.  Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.

Authors:  Peter W West; Lisa C Parker; Jon R Ward; Ian Sabroe
Journal:  Immunology       Date:  2008-03-18       Impact factor: 7.397

9.  Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.

Authors:  Tsuyoshi Kasama; Sakiko Isojima; Masayu Umemura; Hiroyuki Tsukamoto; Takehiro Tokunaga; Hidekazu Furuya; Ryo Yanai; Ryo Takahashi; Masanori Nakamura; Katsunori Inagaki
Journal:  Rheumatol Int       Date:  2013-05-14       Impact factor: 2.631

10.  Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance.

Authors:  Nympha B D'Souza El-Guindy; Willem J de Villiers; Dennis E Doherty
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.